NCT06652464View on ClinicalTrials.gov

Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

November 1, 2024

Study Completion Date

November 15, 2024

Conditions
Disease ActivityRemission of Ulcerative ColitisUlcerative Colitis Flare
Trial Locations (1)

06200

Abdurrahman Yurtaslan Oncology and Training Research Hospital, Ankara

All Listed Sponsors
lead

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

OTHER

NCT06652464 - Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis | Biotech Hunter | Biotech Hunter